Farmax India has informed that the Board Meeting of the Company will be held on November 11, 2016, to consider and approve Unaudited Q2 results and Limited Review report for the quarter ended September 30, 2016. In this connection, the trading window shall remain closed for all the Directors / Officers / Designated employees / Promoters of the Company from day of October 31, 2016 till day of November 11, 2016.
The above information is a part of company’s filings submitted to BSE.